Mono-agonist (like semaglutide) activates one receptor GLP-1
Months 6 to 12: Full evaluation window
Cagrilintide is a long-acting amylin receptor agonist designed to mimic the naturally occurring hormone amylin, which is co-secreted with insulin by pancreatic beta cells
Alternating between them mimics the natural timing of the bodys response to exercise first initiating repair (MGF) and then driving sustained growth and protein synthesis (IGF-1 LR3)
FDA Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (April 2026) Mentioned in This Article: Sermorelin When included as part of a comprehensive weight loss plan, sermorelin can help improve body composition, break down stored fat, and avoid the loss of muscle mass, which can be a detrimental effect of weight loss programs
For those averse to injections, the introduction of sublingual semaglutide offers a needle-free alternative